- $398.62m
- $290.26m
- $4.53m
- 50
- 10
- 62
- 35
Annual cashflow statement for AbSci, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -14.4 | -101 | -105 | -111 | -103 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.881 | 45.8 | 12.6 | 30.5 | 17.7 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.01 | -3.15 | -1.54 | 1.52 | -0.368 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -11 | -60.6 | -81.3 | -64.6 | -72.4 |
Capital Expenditures | -2.18 | -38 | -16.2 | -0.86 | -0.404 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.01 | -29.3 | -111 | 82.8 | -41.2 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -2.17 | -67.4 | -127 | 81.9 | -41.6 |
Financing Cash Flow Items | 0.632 | 0 | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 71 | 336 | 5.24 | -4.48 | 82.5 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 57.8 | 208 | -203 | 12.8 | -31.5 |